Tonix Pharmaceuticals Files 8-K

Ticker: TNXP · Form: 8-K · Filed: Jul 21, 2025 · CIK: 1430306

Sentiment: neutral

Topics: 8-K, filing, disclosure

Related Tickers: TONX

TL;DR

TONX filed an 8-K, likely with updates. Check for details.

AI Summary

Tonix Pharmaceuticals Holding Corp. filed an 8-K on July 21, 2025, reporting on other events and financial statements. The filing does not contain specific financial figures or details about the 'other events' in the provided text.

Why It Matters

This 8-K filing indicates that Tonix Pharmaceuticals is disclosing material information to the public, which could impact investor understanding of the company's current status.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for reporting events and financial statements, with no immediate indication of significant negative developments in the provided text.

Key Players & Entities

FAQ

What specific 'Other Events' are being reported by Tonix Pharmaceuticals in this 8-K filing?

The provided text for the 8-K filing does not specify the details of the 'Other Events' being reported.

When was this 8-K report filed with the SEC?

This 8-K report was filed on July 21, 2025.

What is the principal executive office address for Tonix Pharmaceuticals Holding Corp.?

The principal executive office is located at 26 Main Street, Chatham, New Jersey, 07928.

What is the Commission File Number for Tonix Pharmaceuticals Holding Corp.?

The Commission File Number for Tonix Pharmaceuticals Holding Corp. is 001-36019.

What is the IRS Employer Identification Number (EIN) for Tonix Pharmaceuticals Holding Corp.?

The IRS Employer Identification Number for Tonix Pharmaceuticals Holding Corp. is 26-1434750.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 21, 2025 regarding Tonix Pharmaceuticals Holding Corp. (TNXP).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing